Mobilization of hematopoietic cells

Details Mobilization of hematopoietic cells Mobilization of hematopoietic cells

2004-08-12

2008-08-26

Monshipouri, Maryam (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07417026

ABSTRACT:
Improved methods and pharmaceutical compositions are provided herein for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood, comprising the administration of an effective amount of an inhibitor of GTPases, such as Rac1 and Rac2 alone or in combination. Specifically, methods are disclosed for mobilizing hematopoietic stem cells into a subject's peripheral blood. In particular, embodiments of the method involve inhibition of both Rac1 and Rac2 GTPases to increase the numbers of hematopoietic stem cells into a subject's peripheral blood of a subject. The subject's blood can be processed and used to repopulate the destroyed lymphohematopoietic system of a recipient and may in the future be utilized to repair a variety of non-hematopoietic tissues. Therefore, hematopoietic stem cells mobilized into a subject's peripheral blood by the method of the invention is useful as a source of donor cells in bone marrow transplantation for the treatment of a variety of disorders, including cancer, anemia, autoimmunity and immunodeficiency. They can also be used for increasing white blood cell survival and for chemotherapy.

REFERENCES:
patent: 4997834 (1991-03-01), Muro et al.
patent: 5492898 (1996-02-01), Bertics et al.
patent: 6117850 (2000-09-01), Bleicher et al.
patent: 6451825 (2002-09-01), Uehara et al.
patent: 6620591 (2003-09-01), Dunlay et al.
patent: 6642263 (2003-11-01), Sun et al.
patent: 2 467 557 (2003-05-01), None
patent: WO 97/30992 (1997-08-01), None
patent: WO 99/40783 (1999-08-01), None
patent: WO 01/78761 (2001-10-01), None
patent: WO 01/83745 (2001-11-01), None
patent: WO 01/93900 (2001-12-01), None
patent: WO 01/97608 (2001-12-01), None
patent: WO 03/011277 (2003-02-01), None
patent: WO 03/042239 (2003-05-01), None
patent: WO 2004/091654 (2004-10-01), None
patent: WO 2005/017161 (2005-02-01), None
patent: WO 2005/056024 (2005-06-01), None
Moebest et al., Blood, Nov. 2000, vol. 96, No. 11, part 1, pp. 6897a.
International Search Report issued on the corresponding PCT Application No. PCT/US04/026459, dated Feb. 23, 2005.
Fritz, G. et al., “Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters,” British Journal of Cancer, vol. 87, 635-644 (2002), XP002319076.
Gao Yuan et al., “Rational design and characterization of a Rac GTPase-specific small molecule inhibitor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, No. 20, May 18, 2004, pp. 7618-7623. XP002312007.
Gu Yi et al., “Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases,” Science, vol. 302, No. 5644, pp. 445-449 (2003). XP002312006, Washington DC, ISSN: 0036-8075.
Gu, Y. et al., “Rac2, a hematopoiesis-specific Rho GTPase, specifically regulates mast cell protease gene expression in bone marrow-derived mast cells,” Molecular and Cellular Biology, vol. 22, No. 21, Nov. 2002, 7645-7657, XP002319073.
Gu, Y. et al., “RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration and engraftment of hematopoietic progenitor cells,” Hematopoiesis, vol. 105, No. 4, Feb. 2005, 1467-1475, XP002319078.
Hakoshima, T. et al., “Structural Basis of the Rho GTPase signaling,” J. Biochem., vol. 134, 327-331 (2003), XP002319077.
Li, X. et al., Molecular and Cellular Biology, vol. 22, No. 4, Feb. 2002, 1158-1171, XP002319074.
Llevadot, J. et al., “HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells,” J. Clin. Investig., vol. 108, No. 3, Aug. 2001, 399-405, XP002974000.
Michaelson et al., “Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding,” Journal of Cell Biology. Jan. 8, 2001, 11-126, vol. 152, No. 1.
Moon et al., “Rho GTPase-activating proteins in cell regulation,” Trends in Cell Biology, Jan. 2003, 13-22, vol. 13, No. 1.
Narumiya, S. et al., Cell Signal, 5, 9-19 (1993).
Sahai et al., “Rho-GTPases and Cancer,” Nature Reviews. Cancer., Feb. 2002, 133-142, vol. 2, No. 2.
Sekine, A. et al., J. Biol. Chem., 264, 8602-8605 (1989).
Somiyo, Nature, 389: 908-910 (1997).
Tao et al., “The TRQQRP motif located near the C-terminus of Rac2 is essential for Rac2 biologic functions and intracellular localization,” Blood, Sep. 1, 2002, 1686-1687, vol. 100, No. 5.
Uehata et al., Nature, 389: 990-994 (1997).
Vojtek, A. B. et al., Cell, 82: 527-529 (1995).
Wang Lei et al., “A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells,” Journal of Biological Chemistry, vol. 278, No. 45, Nov. 7, 2003, pp. 44617-44625, XP002312008, ISSN: 0021-9258.
Wennerberg et al., “Rho-family GTPases: it's not only Rac and Rho (and I like it),” Journal of Cell Science, Mar. 15, 2004, 1301-1312, vol. 117, No. 8.
Abo, A. et al.,Nature, 1991, 668-70, 353.
Allen, W.E. et al.,J Cell Biol, 1998, 1147-1157, 160.
Benard, V. et al.,J Biol Chem, 1999, 13198-204, 274.
Croker, B.A. et al.,J Immunol, Apr. 1, 2002, 3376-3386, 168.
Del Pozo, M.A. et al.,Nat Cell Biol, Mar. 2002, 232-9, 4.
Diekmann, D. et al.,Embo J, 1995, 5297-5305, 14.
Etienne-Manneville, S. et al.,Nature, Dec. 12, 2002, 629-635, 420.
Gu, H. et al.,Science, 1994, 103-106, 265.
Hall, A.,Science, 1998, 509-514, 279.
Innocenti, M. et al.,J Cell Biol, Jan. 6, 2003, 17-23, 160.
Kennedy, S.G. et al.,Genes Dev, 1997, 701-713, 11.
Knaus, U.G. et al.,Science, 1991, 1512-5, 254.
Li, B. et al.,Science, 2000, 2219-2222, 288.
Minden, A. et al.,Science, Dec. 9, 1994, 1719-23, 266.
Moll, J. et al.,Oncogene, 1991, 863-866, 6.
Nobes, C.D. et al.,Cell, 1995, 53-62, 81.
Olson, M.F. et al.,Science, 1995, 1270-1272, 269.
Palacios, R. et al.,Proc Natl Acad Sci U S A, May 28, 1996, 5247-5252, 93.
Papayannopoulou, T. et al.,Acta Haematol, 1997, 97-104, 97.
Papayannopoulou, T. et al.,Blood, Feb. 20, 2003, 141.
Ridley, A.J. et al.,Cell, 1992, 401-410, 70.
Roberts, A.W. et al.,Immunity, 1999, 183-196, 12.
Sherr, C.J. et al.,Genes Dev, May 15, 1995, 1149-1163, 9.
Shirsat, N.V. et al.,Oncogene, 1990, 769-772, 5.
Srinivasan, S. et al.,J. Cell Biol, Feb. 3, 2003, 375-85, 160.
Van Aelst, L. et al.,Genes Dev, 1997, 2295-2322, 11.
Williams, D.A. et al.,Blood, 2000, 1646-1654, 96.
Yang, F.C. et al.,Immunity, 2000, 557-568, 12.
Yang, F.C. et al.,Proc Natl Acad Sci U S A, 2001, 5614-5618, 98.
European Office Action issued on the corresponding European Patent Application No. 04781185.6, dated May 14, 2007.
Göttig, S. et al., “Role of the monomeric GTPase Rho in hematopoietic progenitor cell migration and transplantation,” Eur. J. Immunol., 36:180-189 (2006).
Henschler, R. et al., “SDF-1α-induced intracellular calcium transient involves Rho GTPase signalling and is required for migration of hematopoietic progenitor cells,” Bioch. And Biophys. Res.Com, 311:1067-1071 (2003).
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Zhang et al.,Biochemistry, 37:5249-5257 (1998).
U.S. National Library of Medicine's controlled vocabulary database used for indexing articles for Medline/PubMed, Definition of “rho GTP-Binding Proteins”, Jun. 13, 2007.
Judkins et al., “Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1,” Mutation Research, 573:168-179 (2005).
File History of the related U.S. Appl. No. 10/918,648, for the period of Jun. 22, 2007-Sep. 18, 2007.
File History of the related U.S. Appl. No. 11/003,935, for the period of Jun. 22, 2007-Sep. 18, 2007.

Affiliated with

Also associated with

Rating

Mobilization of hematopoietic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mobilization of hematopoietic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mobilization of hematopoietic cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3986404